Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives
From MaRDI portal
Publication:2092087
DOI10.3934/mbe.2021315zbMath1501.92042OpenAlexW3184542219MaRDI QIDQ2092087
Frederick R. Adler, Cassidy K. Buhler, Kathryn G. Link, Rebecca S. Terry
Publication date: 2 November 2022
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2021315
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Related Items
Cites Work
- Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy
- Feedback regulation in a cancer stem cell model can cause an Allee effect
- Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer
- A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications
- Combination therapies and intra-tumoral competition: insights from mathematical modeling
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
- Capitalizing on competition: an evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections
- A mathematical model of tumor-immune interactions
- Analysis of mathematical model of prostate cancer with androgen deprivation therapy
- Ultimate dynamics and optimal control of a multi-compartment model of tumor resistance to chemotherapy
- A mathematical model of intermittent androgen suppression for prostate cancer
- Comparison between mathematical models of intermittent androgen suppression for prostate cancer
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Cellular interactions constrain tumor growth
